Puma Biotechnology, Inc. (PBYI)

NASDAQ: PBYI · Real-Time Price · USD

8.83

+0.12 (1.38%)

At close: Aug 14, 2026, 4:00 PM EDT

8.90

+0.07 (0.79%)

After-hours: Aug 14, 2026, 7:36 PM EDT

Puma Biotechnology Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Revenue	231.24	228.37	230.47	235.64	228.03	253.16
Revenue Growth	-2.86%	-0.91%	-2.19%	3.34%	-9.92%	12.46%
Cost of Revenue	58.2	58.16	64.4	62.68	55.09	63.7
Gross Profit	173.05	170.21	166.06	172.96	172.94	189.45
Selling, General & Admin	71.17	70.85	80.16	89.93	89.98	116.29
Research & Development	71.44	62.07	54.94	50.38	52.24	71.87
Operating Expenses	142.61	132.92	135.1	140.32	142.22	188.16
Operating Income	30.44	37.3	30.97	32.64	30.72	1.29
Interest Expense	-3.52	-6.62	-12.45	-13.33	-11.59	-12.81
Interest & Investment Income	3.85	4.08	4.72	2.61	0.81	0.16
Other Non Operating Income (Expenses)	0.4	1.03	0.86	0.76	-0.03	0.29
EBT Excluding Unusual Items	31.17	35.78	24.1	22.67	19.91	-11.07
Legal Settlements	-	-	-	-	-12.46	-9.59
Other Unusual Items	-	-	-	-	-	-8.15
Pretax Income	31.17	35.78	24.1	22.67	0.46	-28.8
Income Tax Expense	4.45	4.67	-6.18	1.08	0.46	0.32
Net Income	26.72	31.11	30.28	21.59	0	-29.13
Net Income to Common	26.72	31.11	30.28	21.59	0	-29.13
Net Income Growth	-44.86%	2.75%	40.23%	1079450.00%	-	-
Shares Outstanding (Basic)	51	50	49	47	45	41
Shares Outstanding (Diluted)	52	51	49	48	45	41
Shares Change	3.62%	3.16%	3.26%	5.83%	10.56%	2.69%
EPS (Basic)	0.53	0.62	0.62	0.46	0.00	-0.72
EPS (Diluted)	0.50	0.61	0.62	0.45	0.00	-0.72
EPS Growth	-48.22%	-1.61%	37.78%	1022625.00%	-	-

Additional Metrics

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Free Cash Flow	41.16	41.73	38.86	26.87	-15.83	20.65
Free Cash Flow Per Share	0.80	0.82	0.79	0.56	-0.35	0.51
Gross Margin	74.83%	74.53%	72.06%	73.40%	75.84%	74.84%
Operating Margin	13.16%	16.33%	13.44%	13.85%	13.47%	0.51%
Profit Margin	11.55%	13.62%	13.14%	9.16%	0.00%	-11.51%
Free Cash Flow Margin	17.80%	18.27%	16.86%	11.40%	-6.94%	8.16%
EBITDA	40.12	47.44	41.09	42.86	40.56	12.6
EBITDA Margin	17.35%	20.77%	17.83%	18.19%	17.79%	4.98%
D&A For EBITDA	9.68	10.14	10.12	10.22	9.84	11.31
EBIT	30.44	37.3	30.97	32.64	30.72	1.29
EBIT Margin	13.16%	16.33%	13.44%	13.85%	13.47%	0.51%
Effective Tax Rate	14.28%	13.05%	-	4.78%	99.56%	-
Revenue as Reported	231.24	228.37	230.47	235.64	228.03	253.16

SEC Filings: 10-K · 10-Q